miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives
International Journal of Molecular Sciences · 08.03.2023 · 24 (6) · 5192
DOI: 10.3390/ijms24065192 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.03.2023. Verfasst von Francesco Sessa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, 95121 Catania, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Failure, MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Catania.
Abstract (Originalsprache)
MicroRNAs (miRNAs), small noncoding RNAs, are post-transcriptional gene regulators that can promote the degradation or decay of coding mRNAs, regulating protein synthesis. Many experimental studies have contributed to clarifying the functions of several miRNAs involved in regulatory processes at the cardiac level, playing a pivotal role in cardiovascular disease (CVD). This review aims to provide an up-to-date overview, with a focus on the past 5 years, of experimental studies on human samples to present a clear background of the latest advances to summarize the current knowledge and future perspectives. SCOPUS and Web of Science were searched using the following keywords: (miRNA or microRNA) AND (cardiovascular diseases); AND (myocardial infarction); AND (heart damage); AND (heart failure), including studies published from 1 January 2018 to 31 December 2022. After an accurate evaluation, 59 articles were included in the present systematic review. While it is clear that miRNAs are powerful gene regulators, all the underlying mechanisms remain unclear. The need for up-to-date data always justifies the enormous amount of scientific work to increasingly highlight their pathways. Given the importance of CVDs, miRNAs could be important both as diagnostic and therapeutic (theranostic) tools. In this context, the discovery of “TheranoMIRNAs” could be decisive in the near future. The definition of well-setout studies is necessary to provide further evidence in this challenging field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, 95121 Catania, Italy.
ORCID-Profile: Francesco Sessa, Massimiliano Esposito, Cristoforo Pomara
Förderung
- University of Catania
Zitieren
APA
Sessa, F., Salerno, M., Esposito, M., Cocimano, G., & Pomara, C. (2023). miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives. International Journal of Molecular Sciences, 24(6), 5192. https://doi.org/10.3390/ijms24065192
Vancouver
Sessa F, Salerno M, Esposito M, Cocimano G, Pomara C. miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives. International Journal of Molecular Sciences. 2023;24(6):5192. doi:10.3390/ijms24065192
BibTeX
@article{Sessa2023,
author = {Sessa, Francesco and Salerno, Monica and Esposito, Massimiliano and Cocimano, Giuseppe and Pomara, Cristoforo},
title = {miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5192},
doi = {10.3390/ijms24065192}
}
EUVIMED